Swiss Life Asset Management Ltd Has $9.21 Million Stake in Axon Enterprise, Inc $AXON

Posted by Francis Steltz on May 13th, 2026

Swiss Life Asset Management Ltd grew its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 14.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,208 shares of the biotechnology company’s stock after buying an additional 2,055 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Axon Enterprise were worth $9,205,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $29,000. Sound Income Strategies LLC lifted its holdings in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $30,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $34,000. Finally, Lodestone Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $35,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the transaction, the insider directly owned 55,588 shares of the company’s stock, valued at $29,740,135.88. The trade was a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jeri Williams sold 157 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total value of $76,930.00. Following the sale, the director owned 1,159 shares in the company, valued at approximately $567,910. This represents a 11.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 13,855 shares of company stock worth $7,109,828. 5.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Piper Sandler reduced their price target on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a report on Thursday, May 7th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. TD Cowen reduced their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. UBS Group cut their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. Finally, Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research note on Thursday, May 7th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Get Our Latest Stock Report on Axon Enterprise

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $393.66 on Wednesday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The business’s 50 day moving average is $443.50 and its two-hundred day moving average is $521.18. The company has a market cap of $31.73 billion, a P/E ratio of 158.10, a P/E/G ratio of 9.28 and a beta of 1.44. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. The company had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.47 EPS. On average, equities analysts expect that Axon Enterprise, Inc will post 1.41 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.